Old Articles: <Older 1721-1730 Newer> |
|
The Motley Fool April 12, 2007 Dave Mock |
Deutsche Telekom's Crumbling Monopoly With the company in the midst of major reforms, significant risk still exists for investors. Deutsche Telekom cut its earnings forecast for 2007 again in January, citing the brutal competitive environment. |
The Motley Fool April 11, 2007 Emil Lee |
AXA Having a Warm Winterthur French insurer AXA is looking for synergy from the Winterthur acquisition. Investors, although it's still too early to judge, so far the merger is paying off very well. |
The Motley Fool April 10, 2007 Tom Taulli |
webMethods' Last Hurrah With its stock in a rut since 2004, webMethods finally found a way to boost its share price. Last week, the company agreed to sell out to Germany-based Software AG for $546 million in cash. |
InternetNews April 9, 2007 Nicholas Carlson |
AFP Says 'Oui' to Google News Google News will once again index content from the Agence France-Presse, settling a lawsuit the French news agency brought against the search engine giant in 2005. |
The Motley Fool April 9, 2007 Rick Aristotle Munarriz |
Nipping at Google's Ankles Attacking Google from the ground up may not work. Ask.com launched an edgy marketing campaign in the U.K. last month, targeting top dog Google. Why pick a fight in disguise with a bully you can't beat when that time is better spent singing your own praises? |
InternetNews April 5, 2007 Michael Hickins |
Microsoft: We're 'in Full Compliance' With EU Microsoft maintains that its licensing protocols are fair and plans to say it out loud. |
The Motley Fool April 5, 2007 Seth Jayson |
How YOU Doin', Natuzzi? A slowdown in the Italian furniture maker's biz may make for a good buy. |
The Motley Fool April 4, 2007 Dave Mock |
Ma Bell Goes Shopping in Italy AT&T and partners want to control the company in charge of Italy's biggest phone company. Investors, take note. |
The Motley Fool April 4, 2007 Brian Lawler |
GlaxoSmithKline Gets Ready for the Vaccine Wars British pharmaceutical powerhouse GlaxoSmithKline submits a marketing application to the FDA for its HPV vaccine. Investors, take note. |
The Motley Fool April 4, 2007 Dale Baker |
Wendel Wins Again Europe's Berkshire Hathaway delivers another solid report. Wendel's goal for 2012 is simple: Double the group's value again. |
<Older 1721-1730 Newer> Return to current articles. |